XML 23 R7.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
Series C
Preferred Stock
Common Stock
Additional Paid In Capital
Treasury Stock
Accumulated Other Comprehensive Gain
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 197 $ 12,324,646 $ (3,262,577) $ 9,062,266
Balance (in Shares) at Dec. 31, 2021 227 1,972,739          
Sales of common stock $ 115 4,940,833 4,940,948
Sales of common stock (in Shares)   1,150,000          
Accretion of stock options expense to stock based compensation 111,014 111,014
Common shares issued for professional fees $ 2 135,098 135,100
Common shares issued for professional fees (in Shares)   20,000          
Common stock issued for conversion of Series C preferred stock $ 2 (2)
Common stock issued for conversion of Series C preferred stock (in Shares) (227) 15,167          
Rounding of share due to reverse stock split (in Shares) 891          
Net loss (3,908,551) (3,908,551)
Balance at Dec. 31, 2022 $ 316 17,511,589 (7,171,128) 10,340,777
Balance (in Shares) at Dec. 31, 2022   3,158,797          
Accretion of stock options expense to stock based compensation 14,125 14,125
Purchase of treasury stock $ (471,121) (471,121)
Purchase of treasury stock (in Shares)       252,855      
Accumulated other comprehensive loss - short-term investments (6,227) (6,227)
Rounding of share due to reverse stock split (in Shares) 299          
Net loss (3,700,683) (3,700,683)
Balance at Dec. 31, 2023 $ 316 $ 17,525,714 $ (471,121) $ (6,227) $ (10,871,811) $ 6,176,871
Balance (in Shares) at Dec. 31, 2023 3,159,096   252,855